Dietary Supplements Market Research Reports & Industry Analysis
Dietary supplements are regulated by the Food and Drug Administration’s (FDA) Center for Food Safety and Applied Nutrition (CFSAN). Except in the case of a new dietary ingredient, dietary supplements do not need approval by the FDA before being marketed. Under DSHEA, manufacturers must assure that the dietary supplements it manufactures or distributes are safe and that any claims made about them are demonstrated by sufficient data to show that they are not false or misleading.
DSHEA influences the manufacture of dietary supplements by setting forth a number of rules and guidelines. These include: the establishment of a new plan for assuring safety, nutrition and ingredient labeling specifications, outlining directives for marketing literature, regulation for the use of claims and nutritional support statements, and grant to the FDA the authority to establish good manufacturing practice (GMP) regulations.
Dietary Supplements Industry Research & Market Reports
-
Pre-Workout Supplements
... CAGR of 7.0% over the analysis period 2024-2030. Pre-Workout Supplement Powder, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$25.7 Billion by the end of the ... Read More
-
Temperature Controlled Packaging Solutions
... 2030, growing at a CAGR of 19.3% over the analysis period 2024-2030. Insulated Shippers, one of the segments analyzed in the report, is expected to record a 20.0% CAGR and reach US$162.1 Billion by the ... Read More
-
Cold and Flu Supplements
... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Vitamins & Minerals, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$10.8 Billion by ... Read More
-
Folic Acid
... CAGR of 6.3% over the analysis period 2024-2030. Tablets Form, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$479.2 Million by the end of the analysis ... Read More
-
Food Fortifying Agents
... at a CAGR of 9.1% over the analysis period 2024-2030. Vitamins, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$38.5 Billion by the end of the ... Read More
-
Feed Premixes
... CAGR of 6.0% over the analysis period 2024-2030. Amino Acids Ingredient, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$14.1 Billion by the end of the ... Read More
-
Krill Oil
... CAGR of 10.1% over the analysis period 2024-2030. Krill Oil Softgels, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$485.1 Million by the end of the ... Read More
-
Coenzyme Q10
... CAGR of 4.5% over the analysis period 2024-2030. Dietary Supplements Application, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$609.1 Million by the end of the ... Read More
-
Animal Feed Additives
... at a CAGR of 5.4% over the analysis period 2024-2030. Amino Acids, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$20.7 Billion by the end of ... Read More
-
Algae Omega 3 Ingredients
... 2030, growing at a CAGR of 9.8% over the analysis period 2024-2030. EPA / DHA, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$1.0 Billion by ... Read More
-
Immune Health Supplements
... at a CAGR of 8.5% over the analysis period 2024-2030. Vitamins, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$13.1 Billion by the end of the ... Read More
-
Prenatal Vitamin Supplements
... at a CAGR of 6.5% over the analysis period 2024-2030. Gummy, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$174.5 Million by the end of the ... Read More
-
Pet Dietary Supplements
... at a CAGR of 5.2% over the analysis period 2024-2030. Dietary Supplements for Dogs, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$2.3 Billion by the ... Read More
-
Botanical Extracts
... CAGR of 8.6% over the analysis period 2024-2030. Spices Source, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$4.8 Billion by the end of the analysis ... Read More
-
Herbal Medicines
... CAGR of 7.9% over the analysis period 2024-2030. Herbal Pharmaceuticals, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$106.6 Billion by the end of the analysis ... Read More
-
Vitamins
... 6.0% over the analysis period 2024-2030. Vitamin B, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.5 Billion by the end of the analysis period. Growth ... Read More
-
Eye Health Supplements
... at a CAGR of 4.9% over the analysis period 2024-2030. Tablet Form, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.2 Billion by the end of ... Read More
-
Beta Carotene
... CAGR of 4.8% over the analysis period 2024-2030. Natural Beta Carotene, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$459.0 Million by the end of the ... Read More
-
Fatty Acid Supplements
... at a CAGR of 11.7% over the analysis period 2024-2030. Marine Oils, one of the segments analyzed in the report, is expected to record a 11.2% CAGR and reach US$11.8 Billion by the end of ... Read More
-
Brain Health Supplements
... at a CAGR of 5.4% over the analysis period 2024-2030. Natural Molecules, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$6.8 Billion by the end of ... Read More
-
Herbal Supplements
... CAGR of 6.6% over the analysis period 2024-2030. Echinacea Source, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$899.7 Million by the end of the analysis ... Read More
-
Sodium Butyrate
... CAGR of 9.1% over the analysis period 2024-2030. The U.S. Market is Estimated at US$72.8 Million While China is Forecast to Grow at 13.3% CAGR The Sodium Butyrate market in the U.S. is estimated at ... Read More
-
Mycoprotein
... 5.7% over the analysis period 2024-2030. Food & Beverage Application, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$523.4 Million by the end of the analysis ... Read More
-
Natural Beta Carotene
... at a CAGR of 4.7% over the analysis period 2024-2030. Food & Beverage End-Use, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$103.4 Million by the ... Read More
-
Liver Health Supplements
... at a CAGR of 4.6% over the analysis period 2024-2030. Herbal Supplements, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$750.1 Million by the end of ... Read More
Research Assistance
